You know the routine all too well. Up three or four times a night to urinate. A weak stream that takes forever to start. That constant feeling that your bladder isn't empty. You've been taking medication — tamsulosin, finasteride — but the side effects (dizziness, that persistent brain fog) are wearing you down, and the symptoms still aren't fully controlled. Your urologist mentions TURP — the traditional "gold standard" surgery — but you've heard the stories: catheter for days, weeks of recovery, and the real risk of retrograde ejaculation or erectile dysfunction that could change your life. You're not ready to give up your sex life or take weeks off work. Is there another way?
Benign prostatic hyperplasia (BPH) — a non-cancerous enlargement of the prostate gland — is one of the most common conditions affecting aging men. By age 50, approximately 50 percent of men have some degree of BPH; by age 80, that number rises to 90 percent. As the enlarged prostate presses against the urethra, it causes a cascade of lower urinary tract symptoms (LUTS): frequent urination, nocturia (waking multiple times at night to urinate), weak stream, straining, urgency, and the constant feeling of incomplete emptying. For many men, these symptoms aren't just inconvenient — they disrupt sleep, limit travel, affect work, and significantly reduce quality of life.
For decades, the standard surgical treatment for BPH that hasn't responded to medication has been transurethral resection of the prostate (TURP) — a procedure in which the urologist removes excess prostate tissue through the urethra using a resectoscope. While TURP is effective, it's a surgical procedure that requires anesthesia, a catheter for several days, and typically one to two weeks of recovery. Importantly, TURP carries a significant risk of retrograde ejaculation (where semen enters the bladder instead of exiting through the penis), which affects up to 65 percent of men — and a smaller but real risk of erectile dysfunction. For men who want to preserve sexual function, or who aren't good surgical candidates due to age or comorbidities, TURP can feel like choosing between two undesirable options: live with the symptoms, or trade them for sexual side effects and a long recovery.
But there is another option. Prostatic artery embolization (PAE) is a minimally invasive interventional radiology procedure that offers a dramatically different approach. Instead of surgically removing prostate tissue, the interventional radiologist makes a tiny puncture in the groin (typically through the radial artery in the wrist or femoral artery in the groin), threads a microcatheter into the prostatic arteries under X-ray guidance, and injects tiny embolic particles that block blood flow to the enlarged prostate tissue. Over the following weeks and months, the deprived prostate tissue gradually shrinks — relieving pressure on the urethra and improving urinary symptoms — without any surgical cutting, no catheter, and crucially, no impact on sexual function.
The clinical evidence supports PAE as a safe and effective alternative. Randomized controlled trials have shown that PAE provides improvements in urinary symptoms comparable to TURP, with significantly shorter hospital stays (often same-day or overnight), faster return to normal activities, and minimal risk of retrograde ejaculation or erectile dysfunction. In 2026, the Journal of Vascular and Interventional Radiology published a Delphi consensus on standardized PAE technique — reflecting the growing maturation and acceptance of this procedure.
But in the United States, PAE is expensive. A typical PAE procedure — including interventional radiologist fees, facility charges, anesthesia, and post-procedure care — can cost $21,250 or more. And because PAE is a relatively newer procedure, insurance coverage can be inconsistent, with many patients facing significant out-of-pocket costs.
It's no wonder, then, that a growing number of men with BPH are looking beyond their borders for PAE. And increasingly, they're discovering that **medical treatment in China** offers this cutting-edge minimally invasive procedure at a fraction of the cost.
When people think about **affordable surgery abroad**, BPH treatment might not be the first thing that comes to mind. But China has developed a rapidly growing interventional radiology program — with particular expertise in PAE — and international patients are starting to take notice.
**Dramatic cost savings.** This is where the numbers really speak. PAE in China typically costs $4,500 to $6,200 — compared to $21,250 or more in the United States. That's savings of approximately 70 to 78 percent. Even after factoring in flights, accommodation, and a companion's expenses, the total cost is often dramatically lower than what you'd pay out-of-pocket at home. For men who've been told they need surgery but are facing prohibitive costs or insurance coverage gaps, these savings can be transformative.
**The same procedure, the same technology.** China's leading interventional radiology centers use the same equipment and embolic materials used in Western centers — including high-resolution digital subtraction angiography (DSA) systems, microcatheters, and calibrated embolic particles. The PAE procedure in China follows the same standardized technique described in international consensus guidelines: selective catheterization of the prostatic arteries under angiographic guidance, followed by controlled embolization. The difference isn't the procedure or the technology — it's the price, driven by China's lower operational costs, efficient hospital workflows, and high patient volumes.
**High volume = deep expertise.** China's PAE market is growing rapidly — at approximately 18.7 percent annually — and China's leading interventional radiology centers perform high volumes of PAE procedures. This high volume means that Chinese interventional radiologists have extensive experience with the anatomical variations of the prostatic arteries (which can be complex and variable between patients), refined catheterization techniques, and consistent outcomes. For patients, this depth of experience translates into precise, safe procedures and reliable symptom improvement.
**Minimally invasive, fast recovery.** PAE is performed through a tiny puncture in the wrist or groin — no surgical incisions, no general anesthesia (typically local anesthesia with conscious sedation), and no catheter. Most patients are able to go home the same day or after an overnight stay, and return to normal activities within a few days. For men who want to avoid the prolonged recovery and sexual side effects associated with TURP, PAE offers an appealing alternative. And in China, the cost advantage makes this advanced minimally invasive option accessible to patients who might otherwise be unable to afford it.
**Comprehensive urology care.** China's leading centers offer comprehensive BPH care — from initial evaluation (including prostate ultrasound, uroflowmetry, post-void residual measurement, and PSA testing) through the PAE procedure and post-procedure follow-up. Many centers also offer alternative BPH treatments, including HoLEP (holmium laser enucleation of the prostate), Rezum water vapor therapy, and standard TURP — ensuring that patients receive the treatment that's best for their specific anatomy and symptoms, rather than being funneled into a single procedure.
**Why are prices so much lower?** Beyond the lower operational costs and efficient hospital workflows, China's national volume-based procurement (VBP) reforms have driven down the cost of medical devices, embolic materials, and imaging procedures significantly. Combined with a growing domestic interventional radiology industry and high patient volumes, these savings are passed directly to patients — without compromising on technology, physician expertise, or safety standards.
**International standards of care.** Many **Chinese hospitals for international patients** have interventional radiology departments at Grade 3A hospitals — China's highest hospital classification. These facilities adhere to international infection control protocols, use FDA-approved or CE-marked devices where specified, and follow global best practices for PAE and patient safety. For patients considering an endovascular procedure — where precise catheterization and careful post-procedure monitoring are critical — these standards provide peace of mind that the care they receive meets the highest global benchmarks.
If you're considering PAE abroad, you probably have questions about the process. How does the evaluation work? What about post-procedure follow-up? Is there a language barrier?
Many top Chinese interventional radiology centers offer comprehensive international patient services, including:
- Remote initial consultations based on your existing medical records, prostate ultrasound, uroflowmetry, and PSA results
- Comprehensive pre-procedure evaluation, including prostate MRI (to map the prostatic arteries), uroflowmetry, and lab work
For patients who want support from the very beginning, services like **CNHealthLink** specialize in connecting international patients with China's leading interventional radiology centers. From initial case evaluation through the PAE procedure and follow-up, these platforms help patients navigate the process of seeking **medical treatment in China** — ensuring they have the information and support they need at every step of their BPH treatment journey.
Of course, **affordable surgery abroad** and PAE in China isn't the right choice for everyone. PAE is most appropriate for men with moderate-to-severe lower urinary tract symptoms from BPH who haven't responded to medication, particularly those with larger prostates or those who want to preserve sexual function. Men with suspected prostate cancer, severe bladder stones, or certain anatomical variations may not be good candidates. Patients should also be aware that PAE doesn't work for everyone — while most men experience meaningful improvement in urinary symptoms, outcomes vary, and some men may still require additional treatment later. As with any procedure, there are potential risks — including groin hematoma, non-target embolization, and temporary worsening of symptoms — that should be discussed thoroughly with your interventional radiologist.
But for men with BPH who are tired of frequent nighttime urination, who want to avoid the sexual side effects and long recovery of TURP, or who are facing prohibitive costs for PAE at home, exploring PAE in China could be well worth considering. The combination of the same minimally invasive procedure, high-volume interventional radiologists, comprehensive BPH care, and dramatic cost savings makes China an increasingly attractive destination for BPH treatment.
If you're living with BPH symptoms that are disrupting your life — and you want to explore a minimally invasive option that doesn't require surgery or sacrifice sexual function — know that you have choices. Research accredited interventional radiology centers, compare costs and treatment approaches, and consider reaching out to a medical advisory service that specializes in international urology and interventional care. They can help you understand whether PAE in China might be right for your specific situation.
You don't have to choose between living with urinary symptoms and trading away your quality of life. Sometimes, the path to relief leads further than you think.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making decisions about treatment. Prostate artery embolization is not appropriate for all patients; outcomes vary by individual and are not guaranteed. Patients should be evaluated by a qualified interventional radiologist to determine candidacy.